Rapid Diagnostic Test
First Enzymatic Point of Care
Pulmonescence Diagnostics is developing a low-cost and point-of-care triage diagnostic test for Tuberculosis that would help health-care staff identify patients with Tuberculosis that may need further tests and treatment.
Our technology called Reporter Enzyme Fluorescence (REF) uses substrate-enzyme reactions generating a fluorescent signal in the presence of the enzyme produced by the bacterium of TB. This technology is a rapid, low-cost test that will help diagnosed in less time than current technologies.
Tuberculosis (TB) is the world’s top infectious killer caused by the bacteria Mycobacterium tuberculosis.
TB diagnosis is critical to help patients with Tuberculosis get the treatment they need. Globally, about 10 million people get infected with TB every year, and it is one of the top causes of death and the leading cause from a single infectious agent (above HIV/AIDS).
Some symptoms of active lung TB are cough with sputum and blood, chest pain, and fever.
Our research has been the pathogenesis of bacterial lung infections including tuberculosis. Read our publications to learn more about our technology and tuberculosis disease.